SCHEMBL6568611

SCHEMBL6568611

CC(C)(C)NC(=O)Nc1ccc(F)c(F)c1O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.50
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
MAPK1 P28482 1/20 0.45
ANO1 Q5XXA6 4/20 0.43
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
GAA P10253 2/20 0.41
LMNA P02545 1/20 0.41
MAPT P10636 1/20 0.41
EPHX2 P34913 7/20 0.41
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
TP53 P04637 1/20 0.40
HPGD P15428 1/20 0.40
CASP1 P29466 1/20 0.40
CASP7 P55210 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HSD17B10 Q99714 1/20 0.40
PARP1 P09874 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6568647 0.84 HTT (0.41) HTTMEN1KMT2AANO1GAA
SCHEMBL4345624 0.81 MEN1 (0.56) HTTMEN1KMT2AMAPK1ANO1
SCHEMBL4346771 0.81 POLB (0.51) HTTMEN1KMT2AANO1RAB9A
SCHEMBL6788096 0.78 HDAC1 (0.47) MEN1KMT2ANPC1RAB9AMAPT
SCHEMBL13608008 0.74 ALDH1A1 (0.61) HTTMEN1KMT2AMAPK1NPC1
SCHEMBL7488206 0.74 KMT2A (0.63) HTTMEN1KMT2ANPC1RAB9A
SCHEMBL4348862 0.74 HTT (0.47) HTTMEN1KMT2AMAPK1ANO1
SCHEMBL4346777 0.74 HTT (0.38) HTTANO1NPC1GAALMNA
SCHEMBL4354426 0.72 NPC1 (0.47) HTTMEN1KMT2AMAPK1ANO1
SCHEMBL5594682 0.72 HTT (0.67) HTTMEN1KMT2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1402887-A1 New compounds for the inhibition of undesired cell proliferation and use thereof Jerini AG (DE) 2004-03-31 EP claimed
EP-1402888-A1 The use of substituted carbocyclic compounds as rotamases inhibitors Jerini AG (DE) 2004-03-31 EP claimed